🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for CLABSI - Central Line Associated Bloodstream Infection

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) NCT06822426Phase 324 sites📍 Los Angeles📍 Washington D.C.📍 Doral CorMedix Therapeutics · Tests: (taurolidine and heparin) catheter lock solution, Heparin Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China NCT07255105n/a1 site📍 Nanjing Jianfeng Xie Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial NCT07183592NA27 sites📍 Saint-Pierre📍 Albi📍 Angers University Hospital, Angers · Tests: 7-day Infusion set replacement, 4-day infusion set replacement Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science NCT06085690NA1 site📍 Shanghai Fudan University · Tests: evidence-based intervention Plan for the Prevention of CRBSI in ICU patients
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy